Incyte Licenses Key Microarray, Gene Expression Patents to Agilent | GenomeWeb

NEW YORK, Nov. 5 – Incyte Genomics said Monday that it had licensed its main microarray and gene expression patents to Agilent Technologies, a manufacturer of printed DNA microarrays.

Under the terms of the licensing agreements, Incyte will provide Agilent with its patents for nucleic acid linear amplification, the manufacture and use of DNA microarrays, and the use of gene expression arrays in cancer research and diagnosis. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.